Realize Therapeutics

Realize Therapeutics is a life sciences company developing microbiome solutions. Excessive antibiotics harm the gut microbiome, causing millions to lose key microbes and suffer gut dysbiosis resulting in chronic health problems. Realize’s strategy is to develop, research, and commercialize solutions that restore core deficiencies in the human gut microbiome, based on licensed microbe technology from William Davis, MD. Realize’s proprietary L. Reuteri LRDR™ core microbe technology and formulations have applications as medical nutrition, dietary supplements and potentially, as pharmaceuticals. A revenue-stage business, Realize commercializes its branded products through multiple channels via distributors, strategic partners, and direct-to-consumer.